Hochschulschrift
Epicutanoeus immunotherapy as a novel prophylactic and therapeutic strategy for birch pollen allergy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Frankfurt am Main, Johann Wolfgang Goethe-Univ., Diss., 2014
- Schlagwort
-
Allergie
Immunkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Univ.-Bibliothek Frankfurt am Main
- (wann)
-
2014
- Urheber
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:hebis:30:3-355325
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Siebeneicher, Susanne
- Vieths, Stefan
- Toda, Masako
- Dingermann, Theodor
- Univ.-Bibliothek Frankfurt am Main
Entstanden
- 2014
Ähnliche Objekte (12)
Subcutaneous Immunotherapy with a Depigmented Polymerized Birch Pollen Extract – A New Therapeutic Option for Patients with Atopic Dermatitis
Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract - a new therapeutic option for patients with atopic dermatitis
Local immunotherapy in allergy : 22 tables
Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
Pollen allergy and health behavior: patients trivializing their disease
Specific immunotherapy in respiratory allergy - a decision analytic modelling approach
Klinische Merkmale des Pollen Food Allergy Syndrome in südeuropäischen Ländern
Pollen-derived adenosine is a necessary cofactor for ragweed allergy
Nonlinear dynamics of models describing Th1 Th2 regulation, allergy and venom immunotherapy
Patient preferences in allergy immunotherapy (AIT) in Germany - a discrete-choice-experiment
Patient preferences in allergy immunotherapy (AIT) in Germany: A discrete-choice-experiment
Is pollen production of birch controlled by genetics and local conditions?
Subcutaneous Immunotherapy with a Depigmented Polymerized Birch Pollen Extract – A New Therapeutic Option for Patients with Atopic Dermatitis
Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract - a new therapeutic option for patients with atopic dermatitis
Local immunotherapy in allergy : 22 tables
Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
Pollen allergy and health behavior: patients trivializing their disease
Specific immunotherapy in respiratory allergy - a decision analytic modelling approach
Klinische Merkmale des Pollen Food Allergy Syndrome in südeuropäischen Ländern
Pollen-derived adenosine is a necessary cofactor for ragweed allergy
Nonlinear dynamics of models describing Th1 Th2 regulation, allergy and venom immunotherapy
Patient preferences in allergy immunotherapy (AIT) in Germany - a discrete-choice-experiment
Patient preferences in allergy immunotherapy (AIT) in Germany: A discrete-choice-experiment
Is pollen production of birch controlled by genetics and local conditions?
Subcutaneous Immunotherapy with a Depigmented Polymerized Birch Pollen Extract – A New Therapeutic Option for Patients with Atopic Dermatitis
Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract - a new therapeutic option for patients with atopic dermatitis
Local immunotherapy in allergy : 22 tables
Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
Pollen allergy and health behavior: patients trivializing their disease
Specific immunotherapy in respiratory allergy - a decision analytic modelling approach
Klinische Merkmale des Pollen Food Allergy Syndrome in südeuropäischen Ländern
Pollen-derived adenosine is a necessary cofactor for ragweed allergy
Nonlinear dynamics of models describing Th1 Th2 regulation, allergy and venom immunotherapy
Patient preferences in allergy immunotherapy (AIT) in Germany - a discrete-choice-experiment
Patient preferences in allergy immunotherapy (AIT) in Germany: A discrete-choice-experiment